Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Benjamin Rosen, M.D.

Concepts (75)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Seminoma220231361.700 Why?
Testicular Neoplasms220237611.180 Why?
Neoplasms, Second Primary2202310611.050 Why?
Neoplasms, Germ Cell and Embryonal120234840.630 Why?
Radiotherapy, Intensity-Modulated120208060.480 Why?
Bone Neoplasms2202125250.400 Why?
Orchiectomy220234660.390 Why?
Battered Women12006360.290 Why?
Women's Health Services12006930.280 Why?
Palliative Care1202034900.260 Why?
Sex Offenses120063540.210 Why?
Chemokine CXCL10120223040.190 Why?
Vulnerable Populations120066860.190 Why?
Interleukin-18120222490.190 Why?
Interleukin 1 Receptor Antagonist Protein120222970.190 Why?
Interleukin-8120226900.170 Why?
Neoplasm Staging22023110070.170 Why?
Radiotherapy, Adjuvant1202317700.160 Why?
Clinical Trials, Phase II as Topic120206280.160 Why?
DNA Breaks, Double-Stranded120225940.150 Why?
Pregnant Women120225680.150 Why?
Immunoglobulin M1202215380.150 Why?
Women's Health1200620340.150 Why?
Immunoglobulin Class Switching120182910.140 Why?
Disabled Persons1200612120.140 Why?
Immunoglobulin Heavy Chains120186590.130 Why?
Neoplasm Recurrence, Local2202392300.130 Why?
DNA Replication1202213990.130 Why?
Chromatin Assembly and Disassembly120186350.120 Why?
Radiosurgery1202113280.100 Why?
Neoplasms12020216720.100 Why?
Combined Modality Therapy1202386280.100 Why?
Antibodies, Viral1202231760.090 Why?
Retrospective Studies42023774260.090 Why?
Immunoglobulin G1202245590.090 Why?
Tumor Suppressor Proteins1201828480.080 Why?
Cytokines1202273260.070 Why?
Research Design1202059870.060 Why?
Personal Autonomy120062980.060 Why?
Randomized Controlled Trials as Topic1202099600.060 Why?
Karnofsky Performance Status120211730.050 Why?
Telomere-Binding Proteins120221160.050 Why?
Canada1200620650.050 Why?
Male320233500270.050 Why?
Humans720237442200.050 Why?
Pregnancy12022291420.050 Why?
Prognosis12020290500.040 Why?
Follow-Up Studies12020390450.040 Why?
Health Services Needs and Demand1200614110.040 Why?
Somatic Hypermutation, Immunoglobulin12018970.040 Why?
Adolescent22020857590.040 Why?
Social Support1200621170.040 Why?
Cytidine Deaminase120182520.040 Why?
DNA2202273030.030 Why?
Prospective Studies12020532800.030 Why?
Aged, 80 and over12020577680.030 Why?
Female320223801970.030 Why?
Salvage Therapy1202112750.030 Why?
Regulatory Sequences, Nucleic Acid120187940.030 Why?
Young Adult12020564360.030 Why?
Gene Rearrangement1201811790.030 Why?
DNA Repair1202220460.030 Why?
Enhancer Elements, Genetic1201813410.030 Why?
Adult220202140350.020 Why?
Phosphorylation1202284370.020 Why?
Aged120201632530.020 Why?
Promoter Regions, Genetic1201858670.020 Why?
Chromatin1201829340.020 Why?
Middle Aged120202133670.020 Why?
B-Lymphocytes1201846650.020 Why?
Cell Line12018159990.010 Why?
Mice22022811780.010 Why?
Mice, Inbred C57BL12018218240.010 Why?
United States12006698670.010 Why?
Animals220221687880.010 Why?
Rosen's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (75)
Co-Authors (18)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.